Evidence map›Paper›PMID 41127018›Full record

ReviewFrontiers in oncology2025

MRI management of focal liver lesions: what a beginner cannot fail to know.

Vincenza Granata, Roberta Fusco, Igino Simonetti, Maria Giovanna Riga, Giuseppe Pellegrino, Serena Carriero, Michele Ahmed Antonio Karaboue, Gianpaolo Carrafiello, Antonella Petrillo, Francesco Izzo

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vincenza GranataDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Roberta FuscoDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Igino SimonettiDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Maria Giovanna RigaDepartment of Radiology, University of Padova, Padova, Italy.
Giuseppe PellegrinoDiagnostic and Interventional Radiology, Università degli Studi di Milano, Milan, Italy.
Serena CarrieroDiagnostic and Interventional Radiology Department, IRCCS Ca' Granda Fondazione Ospedale Maggiore Policlinico, Milan, Italy.
Michele Ahmed Antonio KaraboueDepartment of Clinical and Experimental Medicine, Section of Legal Medicine, University of Foggia, Foggia, Italy.
Gianpaolo CarrafielloDiagnostic and Interventional Radiology, Università degli Studi di Milano, Milan, Italy.
Antonella PetrilloDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Francesco IzzoDivision of Epatobiliary Surgical Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) is currently recognized as the most suitable diagnostic tool for the detection and characterization of focal liver lesions. The combination of morphological and functional data allows, in different clinical scenarios, high diagnostic performance in characterizing even very small lesions, thereby improving patient management while reducing costs and examination time. Despite this premise, MRI should not be prescribed for all patients with focal liver lesions. Indications must be clearly understood, and the individual characteristics of each patient must be considered. For different clinical scenarios, depending on the presence of extrahepatic malignancy or known liver disease, MRI with contrast agents represents a useful diagnostic tool, although the choice will also depend on operator experience, technology availability, and patient-specific characteristics. A standard protocol should include conventional sequences: T2-weighted (T2W) sequences, T2W sequences with fat suppression (FS), and in-phase and opposed-phase gradient-echo T1 sequences, along with functional sequences. Among functional techniques, diffusion-weighted imaging (DWI) is mandatory, particularly for detecting very small lesions; however, diffusion restriction does not necessarily indicate malignancy. Contrast-enhanced MRI remains the cornerstone of liver MRI, especially for lesion categorization. Contrast agents can be classified as non-specific agents, which distribute into vascular and extracellular extravascular spaces, and specific agents, which are taken up by hepatic cells (Kupffer cells or hepatocytes). The abbreviated protocol concept is based on the premise that, within a shorter examination time, it is possible to acquire the essential information needed for patient management using only selected sequences from a standard protocol. Radiomics has emerged as a promising tool in liver oncology, particularly for evaluating colorectal liver metastases. To fully realize the clinical value of radiomics, it is essential to overcome several methodological hurdles, including the standardization of image acquisition and analysis workflows and rigorous validation across large and diverse patient cohorts. The aim of this review, designed for beginners in liver MRI, is to provide a comprehensive overview of the management of focal liver lesions, with a focus on acquisition protocols (including abbreviated protocols), contrast media, and reporting strategies to ensure accurate lesion characterization.

Indexed as

artificial intelligencecontrast agentsDWIliver focal lesionMRIradiomics

Identifiers

PMID41127018
PMCPMC12537391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.